10:37 AM EDT, 10/01/2024 (MT Newswires) -- Wave Life Sciences ( WVE ) closed the sale of 26.9 million common shares and 1.88 million pre-funded warrants for $230 million in an underwritten public offering.
The offering includes the underwriters' option exercised in full to buy an additional 3.75 million shares at $8 apiece, the company said Tuesday in a statement.
Price: 8.13, Change: -0.07, Percent Change: -0.85